Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)

The Journal of Allergy and Clinical Immunology In Practice(2020)10.1016/j.jaip.2020.06.067Source: DataRank Database

Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST) is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 0.79)OA: greenTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Christian Bime ORCID,Robert J. Henderson ORCID,Kathryn Blake ORCID,Mario Castro ORCID,Emily DiMango ORCID

Live enrichment

PubMed:32693214 PMC:PMC8026280 OpenAlex:https://openalex.org/W3042261979

NCATS NIH HHS

Grant: UL1 TR002366

GlaxoSmithKline

National Heart, Lung, and Blood Institute

Novartis

Gilead Sciences

National Institutes of Health

Sanofi

U.S. Food and Drug Administration

AstraZeneca

Sanofi Genzyme

American Lung Association

National Institute of Allergy and Infectious Diseases

Chiesi Farmaceutici

National Eye Institute

Regeneron Pharmaceuticals

Teva Pharmaceutical Industries

Boehringer Ingelheim

Genentech

National Institute of Dental and Craniofacial Research

FWCI

0.79

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8026280

publisherhttps://api.elsevier.com/content/article/PII:S2213219820307145?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213219820307145?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaip.2020.06.067

Fields of Study

Asthma and respiratory diseasesDelphi Technique in ResearchIL-33, ST2, and ILC Pathways

MeSH Terms

AsthmaBreath TestsHumansInflammationNitric OxideBiomarkersExhalation

Keywords

MedicineExhaled nitric oxideAsthmaInternal medicineBronchodilatorEosinophilBiomarkerDiscontinuationAtopyImmunologySpirometryBiomarkersIgEStep-down TherapyFractional Exhaled Nitric OxideEosinophil Peroxidase

Sustainable Development Goals

SDG 0: Good health and well-being

Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)

FAIR Checklist

Authors (16)

Funding (19 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)